The National Cancer Institute has awarded the U-M Rogel Cancer Center a grant worth $37 million over five years and renewed the center’s designation as a “comprehensive cancer center.”

Research finds genetic testing for cancer can bring more knowledge to patients and their relatives, but not many people get it done.

Sugar free: investigator finds cancer cells use a new fuel in absence of sugar

To combat critical drug shortages, a Michigan Medicine physician advocates for better solutions to the ongoing supply chain issues regarding medications in the United States.

A team of Michigan Medicine researchers have identified a mechanism in mice for how obesity affects some oral cancers’ ability to escape from the immune system.

For thyroid cancer, experts examine the current state of overdiagnosis, new therapies, health equity concerns and more.

Researchers at Michigan Medicine have identified a new metric to articulate the relationship between nerve density and oral cancer. The study investigated normalized nerve density to translate previous mechanistic studies into a context that could be used in the clinic.

Financial toxicity of cancer impacts partners’ quality of life, with people reporting pain, fatigue and sleep issues tied to missed work and medical bills

A research partnership has revealed a new pathway to understanding the progression of pancreatic cancer.

A variety of factors affect the barriers that patients with cancer foresee to undergoing genetic testing, researchers found, but the issues that motivate patients to actually follow through with genetic testing remain unclear.

Michigan Medicine researchers used microfluidic devices to track what happens to cancer cells as they migrate and take root in the brain.

Genetic testing for hereditary conditions such as breast cancer can have implications for the whole family. Learn how genetic testing helped Cathleen Argyle and her family to uncover a rare mutation and how the Rogel Cancer Center provided advice and guidance throughout the process.

A new study finds AI-based diagnostic screening system, DeepGlioma, detects genetic mutations in brain tumors in under 90 seconds. Streamlining glioma diagnosis and treatment.

What to know about an at-home colorectal cancer screening test versus a colonoscopy

By feeding T cells in the lab, researchers revealed a new metabolic pathway that could help make immunology more effective.